<DOC>
	<DOCNO>NCT00285142</DOCNO>
	<brief_summary>To evaluate : - acute effect single dose 8 mg rosiglitazone ( therapeutic dose ) - insulin secretion - insulin sensitivity 12 healthy male subject .</brief_summary>
	<brief_title>Effect Rosiglitazone</brief_title>
	<detailed_description />
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>BMI 18.0 24.0</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>rosiglitazone</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>clinical trial</keyword>
	<keyword>healthy</keyword>
	<keyword>person</keyword>
</DOC>